Altaire Pharmaceuticals announced the voluntary recall of multiple ophthalmic prescription drug products. The specific products include:

  • Neomycin and Polymixin B and Bacitracin Zinc Ophthalmic Ointment; NDC Number: 0574-4250-35; Package Size: 3.5g.
  • Neo-Poly Dex (Neomycin and Polymixin B and Dexamethasone) Ophthalmic Ointment; NDC Number: 0574-4160-35; Package Size: 3.5g.
  • Neo-Polycin HC (Neomycin and Polymixin B and Bacitracin Zinc and Hydrocortisone Acetate) Ophthalmic Ointment; NDC Number: 0574-4144-35; Package Size: 3.5g.
  • Polycin (Polymixin B and Bacitracin Zinc) Ophthalmic Ointment; NDC Number: 0574-4021-35; Package Size: 3.5g.
  • Bacitracin Ophthalmic Ointment; NDC Number: 0574-4022-35; Package Size: 3.5g.
  • Sulfacetamide Sodium Ophthalmic Ointment; NDC Number: 0574-4190-35; Package Size: 3.5g.
  • Puralube Ophthalmic Ointment (an OTC product)

The specified lots, within expiry, distributed during the time period for the recalled products can be found here.

The Company is initiating the recall as a precautionary measure due to concerns over the sufficiency of Quality Assurance controls in the manufacturing facility. The recall is being carried out to the retail level and is only for the specific lots mentioned. According to Altaire, no reports of adverse events have been received at this time.

Related Articles

The products are manufactured and labeled exclusively for Perrigo Company PLC. Altaire has notified Perrigo of the impacted products and has requested Perrigo to perform a subrecall as well as to notify its customers.

For more information regarding this recall contact Altaire Pharmaceuticals, by calling 1-800-258-2471 or emailing [email protected]